Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India. India has faced challenges obtaining the needed levels of compliance with its mass drug administration (MDA) program to interrupt LF transmission, which utilizes diethylcarbamazine (DEC) or DEC plus albendazol...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Public Library of Science (PLoS),
2010-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|